It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within o ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin ...

Weight loss drugs like Ozempic and Wegovy dominated 2024. Securing insurance to cover the costs is a different challenge ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

GLP-1s are approved to treat Type-2 diabetes, but are also effective as weight-loss drugs. But GLP-1 users may have to stay on them long-term to maintain their weight loss. Side effects and high ...

Glucagon-like peptide-1 receptor agonist medications for weight loss are significantly transforming the field of facial plastic surgery.

GLP-1s have quickly ... potential of GLP-1 therapy. To achieve the best results, these programmes must focus on breaking down the common barriers that make weight loss so challenging, including ...

Popular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions such as substance abuse, psychosis, infections and even dementia.

[18] There was no significant difference in weight change between any of the albiglutide dosings, with average weightloss being -1.1 to -1.7 kg (less than that observed in the exenatide group of ...